Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment
Research output: Contribution to journal › Journal article › Research › peer-review
Allergen-specific immunotherapy is a well-documented treatment for allergic rhinitis, asthma, and allergy to Hymenoptera venoms. The drawbacks of injection immunotherapy are related to the risk of inducing systemic side-effects (especially during the induction phase), the time used to reach the maintenance dose, and the percentage of patients completing the induction phase).
| Original language | English |
|---|---|
| Journal | Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology |
| Volume | 30 |
| Issue number | 10 |
| Pages (from-to) | 1423-9 |
| Number of pages | 7 |
| ISSN | 0954-7894 |
| Publication status | Published - Oct 2000 |
- Allergens, Female, Humans, Hypersensitivity, Immunotherapy, Male, Retrospective Studies, Sex Factors
Research areas
ID: 50846111